鉴别儿童脓毒症与细胞因子释放综合征的诊断生物标志物
该研究针对接受CD19 CAR-T治疗的复发难治性急性淋巴细胞白血病儿童,比较脓毒症与细胞因子释放综合征(CRS)的细胞因子差异,并构建预测模型。研究识别出23种差异显著的细胞因子,其中IFNγ与IL1β的组合可将受试者分类为CRS或脓毒症,准确率达97%。
要点
- IFNγ显著升高或轻度升高伴IL1β降低提示CRS。
- IFNγ正常至轻度升高伴IL1β升高提示脓毒症。
- IFNγ与IL1β组合分类CRS或脓毒症的准确率为97%。
核心结论
- IFNγ与IL1β的组合可准确区分危重儿童患者的CRS与脓毒症,准确率达97%。
研究设计与样本
- 研究纳入接受CD19 CAR-T治疗的复发难治性急性淋巴细胞白血病儿童,比较脓毒症与CRS患者的细胞因子差异。
主要发现
- 共识别出23种在脓毒症与CRS患者间显著不同的细胞因子。
- 应用弹性网络预测模型和树分类方法,识别出能准确分类CRS或脓毒症的细胞因子。
- IFNγ显著升高或轻度升高伴IL1β降低与CRS相关。
- IFNγ正常至轻度升高伴IL1β升高与脓毒症相关。
- IFNγ与IL1β组合分类CRS或脓毒症的准确率为97%。
临床怎么用
- 在CAR-T治疗后危重患儿中,可检测IFNγ与IL1β组合辅助鉴别CRS与脓毒症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR) T-cells directed against CD19 have drastically altered outcomes for children with relapsed and refractory acute lymphoblastic leukemia (r/r ALL). Pediatric patients with r/r ALL treated with CAR-T are at increased risk of both cytokine release syndrome (CRS) and sepsis. We sought to investigate the biologic differences between CRS and sepsis and to develop predictive models which could accurately differentiate CRS from sepsis at the time of critical illness. We identified 23 different cytokines that were significantly different between patients with sepsis and CRS. Using elastic net prediction modeling and tree classification, we identified cytokines that were able to classify subjects as having CRS or sepsis accurately. A markedly elevated interferon γ (IFNγ) or a mildly elevated IFNγ in combination with a low IL1β were associated with CRS. A normal to mildly elevated IFNγ in combination with an elevated IL1β was associated with sepsis. This combination of IFNγ and IL1β was able to categorize subjects as having CRS or sepsis with 97% accuracy. As CAR-T therapies become more common, these data provide important novel information to better manage potential associated toxicities.
引用
- Diorio C, Shaw PA, Pequignot E, et al. Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children. Blood Adv. 2020. PMID: 33095872. doi:10.1182/bloodadvances.2020002592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。